Advertisement
IQV vs STAA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IQV is a Hold and STAA is a StrongBuy.
Momentum Indicator for IQV turns positive, indicating new upward trend
IQV saw its Momentum Indicator move above the 0 level on October 20, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 76 similar instances where the indicator turned positive. In 52 of the 76 cases, the stock moved higher in the following days. The odds of a move higher are at 68%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for IQV just turned positive on October 21, 2026. Looking at past instances where IQV's MACD turned positive, the stock continued to rise in 24 of 42 cases over the following month. The odds of a continued upward trend are 57%.
Following a +0.99% 3-day Advance, the price is estimated to grow further. Considering data from situations where IQV advanced for three days, in 187 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
The Aroon Indicator entered an Uptrend today. In 120 of 222 cases where IQV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 54%.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IQV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
IQV broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 6 (best 1 - 100 worst), indicating outstanding price growth. IQV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 31 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 43 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.298) is normal, around the industry mean (65.624). P/E Ratio (33.695) is within average values for comparable stocks, (2.414). Projected Growth (PEG Ratio) (0.985) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.693) is also within normal values, averaging (9.775).
The Tickeron Profit vs. Risk Rating rating for this company is 84 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IQV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
STAA's RSI Indicator ascending out of oversold territory
The RSI Indicator for STAA moved out of oversold territory on September 25, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 41 similar instances when the indicator left oversold territory. In 34 of the 41 cases the stock moved higher. This puts the odds of a move higher at 83%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on STAA as a result. In 78 of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.
The Moving Average Convergence Divergence (MACD) for STAA just turned positive on September 29, 2026. Looking at past instances where STAA's MACD turned positive, the stock continued to rise in 35 of 47 cases over the following month. The odds of a continued upward trend are 74%.
STAA moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where STAA advanced for three days, in 192 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The 50-day moving average for STAA moved below the 200-day moving average on September 22, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
STAA broke above its upper Bollinger Band on October 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for STAA entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 44 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. STAA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.188) is normal, around the industry mean (4.950). STAA's P/E Ratio (290.375) is considerably higher than the industry average of (37.710). Projected Growth (PEG Ratio) (2.060) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (3.331) is also within normal values, averaging (56.876).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STAA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
IQV | STAA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 22 | 45 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 74 Overvalued | 98 Overvalued | |
PROFIT vs RISK RATING 1..100 | 84 | 100 | |
SMR RATING 1..100 | 43 | 89 | |
PRICE GROWTH RATING 1..100 | 6 | 51 | |
P/E GROWTH RATING 1..100 | 31 | 44 | |
SEASONALITY SCORE 1..100 | 85 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IQV's Valuation (74) in the Servicestothe Health Industry industry is in the same range as STAA (98) in the Medical Specialties industry. This means that IQV’s stock grew similarly to STAA’s over the last 12 months.
IQV's Profit vs Risk Rating (84) in the Servicestothe Health Industry industry is in the same range as STAA (100) in the Medical Specialties industry. This means that IQV’s stock grew similarly to STAA’s over the last 12 months.
IQV's SMR Rating (43) in the Servicestothe Health Industry industry is somewhat better than the same rating for STAA (89) in the Medical Specialties industry. This means that IQV’s stock grew somewhat faster than STAA’s over the last 12 months.
IQV's Price Growth Rating (6) in the Servicestothe Health Industry industry is somewhat better than the same rating for STAA (51) in the Medical Specialties industry. This means that IQV’s stock grew somewhat faster than STAA’s over the last 12 months.
IQV's P/E Growth Rating (31) in the Servicestothe Health Industry industry is in the same range as STAA (44) in the Medical Specialties industry. This means that IQV’s stock grew similarly to STAA’s over the last 12 months.
| IQV | STAA | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 83% |
| Stochastic ODDS (%) | 2 days ago 75% | 2 days ago 76% |
| Momentum ODDS (%) | 2 days ago 68% | 2 days ago 75% |
| MACD ODDS (%) | 2 days ago 57% | 2 days ago 74% |
| TrendWeek ODDS (%) | 2 days ago 63% | 2 days ago 68% |
| TrendMonth ODDS (%) | 2 days ago 71% | 2 days ago 68% |
| Advances ODDS (%) | 5 days ago 62% | 2 days ago 70% |
| Declines ODDS (%) | 9 days ago 64% | N/A |
| BollingerBands ODDS (%) | 2 days ago 57% | 2 days ago 76% |
| Aroon ODDS (%) | 2 days ago 54% | 2 days ago 85% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
IQV’s FA Score shows that 2 FA rating(s) are green while STAA’s FA Score has 0 green FA rating(s).
- IQV’s FA Score: 2 green, 3 red.
- STAA’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
IQV’s TA Score shows that 4 TA indicator(s) are bullish while STAA’s TA Score has 5 bullish TA indicator(s).
- IQV’s TA Score: 4 bullish, 3 bearish.
- STAA’s TA Score: 5 bullish, 4 bearish.
Price Growth
IQV (@Medical Specialties) experienced а +2.90% price change this week, while STAA (@Pharmaceuticals: Other) price change was +6.17% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +2.19%. For the same industry, the average monthly price growth was -5.98%, and the average quarterly price growth was +48.59%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.27%. For the same industry, the average monthly price growth was -3.10%, and the average quarterly price growth was +10.31%.
Reported Earning Dates
IQV is expected to report earnings on Oct 27, 2026.
STAA is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Medical Specialties (+2.19% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Pharmaceuticals: Other (+0.27% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
Advertisement
STAA and
Correlation & Price change
A.I.dvisor indicates that over the last year, STAA has been loosely correlated with OFIX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if STAA jumps, then OFIX could also see price increases.
| Ticker / NAME | Correlation To STAA | 1D Price Change % | ||
|---|---|---|---|---|
| STAA | 100% | +2.74% | ||
| OFIX - STAA | 38% Loosely correlated | -0.31% | ||
| CSTL - STAA | 38% Loosely correlated | +0.67% | ||
| IQV - STAA | 37% Loosely correlated | -2.06% | ||
| MTD - STAA | 37% Loosely correlated | -0.04% | ||
| FLGT - STAA | 36% Loosely correlated | +0.60% | ||
More | ||||